factually
Index/Organizations/CDC/ACIP

CDC/ACIP

Fact-Checks

2 results
Jan 15, 2026
Most Viewed

Is a single dose novavax 2024/2025 jn1 enough for a SarsCov2 naive individual

A single dose of the Novavax 2024–2025 formulation (JN.1-based) is authorized for use in vaccine‑naïve individuals ≥12 years in the United States, and regulatory documents describe a single‑dose regim...

Nov 26, 2025

Did vaccine type (standard-dose, high-dose, adjuvanted, recombinant, cell-based) affect protection against severe illness in 2025–2026?

Early and mid‑2025 data show vaccine type mattered for protection against severe outcomes for respiratory viruses: high‑dose and some adjuvanted influenza vaccines offered superior protection against ...